Baker Keith
Director/Board Member at Gyroscope Therapeutics Ltd.
Profile
Keith Baker, MD, MBA is a graduate of Duke University, Dartmouth (Geisel) Medical School, and the Amos Tuck School of Business Administration at Dartmouth College.
Dr. Baker completed his Ophthalmology residency training at the University of North Carolina Hospitals in Chapel Hill, NC, where he was selected as Chief Resident during his final year of training.
He completed his board certification in Ophthalmology and was elected to membership in the American Academy of Ophthalmology.
Dr. Baker has participated in eye care medical mission trips to China, El Salvador, and rural Appalachia.
Since 2010, Dr. Baker has worked in the life sciences industry as a strategy consultant and Medical Affairs professional.
In that capacity, Keith has focused on identifying and addressing unmet clinical needs within the Ophthalmology space and has developed extensive experience in market assessment, clinical trial conception and execution, and communication of relevant data to a wide variety of stakeholders.
Dr. Baker has served as an informal adviser to Dr. David Adair on multiple occasions since 2011 and joined the Solas Advisory Board in February of 2021.
Baker Keith active positions
Companies | Position | Start |
---|---|---|
Solas Bioventures (mayfield) LLC
Solas Bioventures (mayfield) LLC Investment ManagersFinance Solas Bioventures (mayfield) LLC is a venture capital firm founded in 2012 by David Adair and Mark Hackett JD. The firm is headquartered in Chattanooga, Tennessee. | Consultant / Advisor | - |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Director/Board Member | 2021-03-31 |
Eyebiotech Ltd.
Eyebiotech Ltd. Pharmaceuticals: MajorHealth Technology Eyebiotech Ltd. develops new generation of therapies for eye diseases. The British company was founded in 2021 by David R. Guyer, Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Private Equity Investor | 2022-12-31 |
Training of Baker Keith
Duke University | Undergraduate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Geisel School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Solas Bioventures (mayfield) LLC
Solas Bioventures (mayfield) LLC Investment ManagersFinance Solas Bioventures (mayfield) LLC is a venture capital firm founded in 2012 by David Adair and Mark Hackett JD. The firm is headquartered in Chattanooga, Tennessee. | Finance |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Eyebiotech Ltd.
Eyebiotech Ltd. Pharmaceuticals: MajorHealth Technology Eyebiotech Ltd. develops new generation of therapies for eye diseases. The British company was founded in 2021 by David R. Guyer, Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Health Technology |
- Stock Market
- Insiders
- Baker Keith